World's Best Scientists 2026 revealed!
Jim A. Julian

Jim A. Julian

D-Index & Metrics

Medicine

D-Index
83
Citations
32476
World Ranking
15428
National Ranking
642

Overview

Jim A. Julian is affiliated with McMaster University in Canada and focuses their research primarily within the fields of Medicine and Health Professions. Their work encompasses several interrelated subfields, including Oncology, Cancer Research, Internal Medicine, General Health Professions, and Emergency Medical Services.

The main topics of Jim A. Julian's research address Breast Cancer Treatment Studies, Venous Thromboembolism Diagnosis and Management, Cancer Survivorship and Care, Central Venous Catheters and Hemodialysis, Healthcare Systems and Technology, Head and Neck Cancer Studies, and Breast Lesions and Carcinomas.

Among recent publications, Jim A. Julian has contributed to studies such as:

  • "Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer," 2020, International Journal of Radiation Oncology*Biology*Physics
  • "Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial," 2021, BMJ
  • "Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study," 2022, BMJ
  • "Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial," 2020, Seminars in Thrombosis and Hemostasis
  • "Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial," 2023, Journal of Medical Internet Research

Jim A. Julian frequently publishes in journals such as BMJ (2 publications), International Journal of Radiation Oncology*Biology*Physics, Seminars in Thrombosis and Hemostasis, Journal of Medical Internet Research, and Blood. Their research traction includes citations from various articles across these venues.

Collaboration is also a component of Jim A. Julian's scientific contributions. Frequent co-authors include Eva Grunfeld, Jonathan Sussman, Clive Kearon, Sam Schulman, and Susan R. Kahn, with repeated partnerships reflecting ongoing research synergies in cancer treatment and thrombosis management.

Best Publications

  • Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

    Agnes Y.Y. Lee;Mark N. Levine;Ross I. Baker;Chris Bowden

  • Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

    Timothy J Whelan;Jean-Philippe Pignol;Mark N Levine;Jim A Julian

  • A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

    Clive Kearon;Michael Gent;Michael Gent;Jack Hirsh;Jack Hirsh;Jeffrey Weitz

  • Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

    Clive Kearon;Jeffrey S. Ginsberg;Michael J. Kovacs;David R. Anderson

  • A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

    Mark A. Crowther;Jeff S. Ginsberg;Jim Julian;Judah Denburg

  • Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis

    Susan R Kahn;Ian Shrier;Jim A Julian;Thierry Ducruet

  • Noninvasive Diagnosis of Deep Venous Thrombosis

    C Kearon;J A Julian;T E Newman;J S Ginsberg

  • Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer

    Timothy Whelan;Robert MacKenzie;Jim Julian;Mark Levine

  • Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis

    Suresh Vedantham;Samuel Z. Goldhaber;Jim A. Julian;Susan R. Kahn

  • Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis

    Timothy J. Whelan;Jim Julian;Jim Wright;Alejandro R. Jadad

  • Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

    Charles N. Catton;Himu Lukka;Chu-Shu Gu;Jarad M. Martin

  • Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism

    Agnes Y.Y. Lee;Frederick R. Rickles;Jim A. Julian;Michael Gent

  • Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care

    Eva Grunfeld;Mark N. Levine;Jim A. Julian;Doug Coyle

  • Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia

    James R. Wright;Yee C. Ung;Jim A. Julian;Kathleen I. Pritchard

  • Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

    R Grilli;A D Oxman;J A Julian

  • Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate.

    Jinka R. Sathya;Ian R. Davis;Jim A. Julian;Qing Guo

  • Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.

    Florent Boutitie;Laurent Pinede;Sam Schulman;Giancarlo Agnelli

  • Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy

    Ivo A. Olivotto;Timothy J. Whelan;Sameer Parpia;Do-Hoon Kim

  • External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.

    Timothy J Whelan;Jim A Julian;Tanya S Berrang;Do-Hoon Kim

  • Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis

    S.R. Kahn;I. Shrier;J.A. Julian

Frequent Co-Authors

Mark Levine
Mark Levine McMaster University
Clive Kearon
Clive Kearon McMaster University
Jeffrey S. Ginsberg
Jeffrey S. Ginsberg McMaster University
Timothy J. Whelan
Timothy J. Whelan McMaster University
James D. Douketis
James D. Douketis McMaster University
Michael Gent
Michael Gent McMaster University
Susan R. Kahn
Susan R. Kahn McGill University
Mark Crowther
Mark Crowther McMaster University
Sam Schulman
Sam Schulman McMaster University
Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine doesn’t stop at becoming a doctor. There are many career paths in healthcare that offer flexibility and growth—many of which can be pursued through online degree programs.

For those interested in leadership roles, a masters in healthcare administration cost is an important consideration. Affordable online programs make it easier to advance your career without heavy financial burdens.

Nursing professionals aspiring to clinical or academic leadership can choose msn to dnp programs online for added flexibility and the opportunity to gain the highest clinical degree.

If pharmacy is your calling, numerous online pharmacy school programs offer advanced study while allowing you to balance other commitments.

Additionally, managing health data is vital in today’s medical field. An accredited health information management degree online can open doors to tech-driven healthcare roles.

By choosing the right online degree, you can tailor your educational journey to fit your career goals, schedule, and budget.

Best Scientists Citing Jim A. Julian

Trending Scientists

Recently Published Articles